GlassScriptPhysician profile
Caroline A Perry
NPI 1548279821
$3,144.35
in general payments reported to CMS, 2019-2025
42 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $190 · 2021: $431 · 2022: $219 · 2023: $560 · 2024: $777 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,986 · Education: $76.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.27 |
| Education | $76.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $304.60 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Teva Pharmaceuticals USA, INC. | $263.80 | 2019-2024 | Austedo Xr |
| Abbvie INC. | $244.83 | 2021-2025 | |
| Ucb, INC. | $209.18 | 2023-2025 | Zilbrysq, Nayzilam, Briviact |
| Novartis Pharmaceuticals Corporation | $189.97 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $175.18 | 2024-2025 | Ultomiris |
| Biogen, INC. | $161.72 | 2019-2024 | Vumerity, Tysabri, Avonex |
| Kyowa Kirin, INC. | $130.11 | 2020-2025 | Nourianz |
| Genentech USA, INC. | $97.68 | 2021-2025 | Ocrevus, Enspryng |
| Merz Pharmaceuticals, LLC | $91.30 | 2024 | Xeomin |
| Sk Life Science, INC. | $89.22 | 2020-2025 | |
| Pfizer INC. | $80.63 | 2023-2025 | |
| Eisai INC. | $74.74 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $74.66 | 2019-2025 | Crexont |
| Allergan, INC. | $70.19 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.